Literature DB >> 1974216

HLA-DQ beta-chain restriction fragment length polymorphism as a risk marker in type 1 (insulin-dependent) diabetes mellitus: a Finnish family study.

H Reijonen1, J Ilonen, M Knip, B Michelsen, H K Akerblom.   

Abstract

Finnish Type 1 (insulin-dependent) diabetic families were analysed for HLA-DQ beta-chain polymorphism using a short intron-specific probe. A simple hybridization pattern was obtained in which all fragments were associated significantly with Type 1 diabetes. The simultaneous presence of two different risk markers, the allelic 12-kilobase and 4-kilobase fragments were strongly associated with Type 1 diabetes since 50% of the patients had this combination compared with only 2% of the control subjects. The cosegregated 7.5/3.0 kilobase fragments, which were associated with HLA-DR2 and DRw6 were not detected among the diabetic patients but were present in 48% of the control subjects. Our results provide further support for the location of susceptibility determining factors in the HLA-DQ gene area. The clear-cut, simple restriction fragment length polymorphism pattern obtained here, which bears a resemblance to a two allelic system, therefore makes this method applicable for estimating the risk of Type 1 diabetes at the population level.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1974216     DOI: 10.1007/bf00404640

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  28 in total

1.  A systematic study of HLA class II-beta DNA restriction fragments in insulin-dependent diabetes mellitus.

Authors:  O Cohen-Haguenauer; E Robbins; C Massart; M Busson; I Deschamps; J Hors; J M Lalouel; J Dausset; D Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

2.  Islet cell and insulin autoantibodies in subjects at high risk for development of type 1 (insulin-dependent) diabetes mellitus: the Lyon family study.

Authors:  C Thivolet; B Beaufrére; H Bétuel; L Gebuhrer; P Chatelain; A Durand; J Tourniaire; R François
Journal:  Diabetologia       Date:  1988-10       Impact factor: 10.122

3.  A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles.

Authors:  M J Sheehy; S J Scharf; J R Rowe; M H Neme de Gimenez; L M Meske; H A Erlich; B S Nepom
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

4.  DQ Wa gives rise to a DQ beta restriction fragment pattern indistinguishable from that of the DQw3.2 sub-type of DQw3.

Authors:  A Bushell; K J Wood; P J Morris
Journal:  Tissue Antigens       Date:  1988-07

5.  Sequence analysis of HLA class II genes from insulin-dependent diabetic individuals.

Authors:  G T Horn; T L Bugawan; C M Long; M M Manos; H A Erlich
Journal:  Hum Immunol       Date:  1988-04       Impact factor: 2.850

6.  Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study.

Authors:  P A Morel; J S Dorman; J A Todd; H O McDevitt; M Trucco
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

7.  The epidemiology of insulin-dependent diabetes mellitus (IDDM) in Finland and in northern Europe.

Authors:  H K Akerblom; A Reunanen
Journal:  Diabetes Care       Date:  1985 Sep-Oct       Impact factor: 19.112

8.  HLA associations in insulin-dependent diabetes: search for heterogeneity in different groups of patients from a homogeneous population.

Authors:  A Svejgaard; B K Jakobsen; P Platz; L P Ryder; J Nerup; M Christy; K Borch-Johnsen; H H Parving; T Deckert; L Mølsted-Pedersen
Journal:  Tissue Antigens       Date:  1986-10

9.  HLA-D region beta-chain DNA endonuclease fragments differ between HLA-DR identical healthy and insulin-dependent diabetic individuals.

Authors:  D Owerbach; A Lernmark; P Platz; L P Ryder; L Rask; P A Peterson; J Ludvigsson
Journal:  Nature       Date:  1983-06-30       Impact factor: 49.962

10.  HLA-DO polymorphism associated with resistance to type I diabetes detected with monoclonal antibodies, isoelectric point differences, and restriction fragment length polymorphism.

Authors:  G M Schreuder; M G Tilanus; R E Bontrop; G J Bruining; M J Giphart; J J van Rood; R R de Vries
Journal:  J Exp Med       Date:  1986-09-01       Impact factor: 14.307

View more
  3 in total

1.  Evidence for an environmental effect in the aetiology of insulin dependent diabetes in a transmigratory population.

Authors:  H J Bodansky; A Staines; C Stephenson; D Haigh; R Cartwright
Journal:  BMJ       Date:  1992-04-18

2.  Antibody reactivity to an Epstein-Barr virus BERF4-encoded epitope occurring also in Asp-57 region of HLA-DQ8 beta chain. Childhood Diabetes in Finland Study Group.

Authors:  P Parkkonen; H Hyöty; J Ilonen; H Reijonen; S Ylä-Herttuala; P Leinikki
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

3.  HLA-DQ primarily confers protection and HLA-DR susceptibility in type I (insulin-dependent) diabetes studied in population-based affected families and controls.

Authors:  I Kockum; R Wassmuth; E Holmberg; B Michelsen; A Lernmark
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.